This trial is testing whether a high dietary fiber formula can reduce chemotherapy-induced diarrhea in patients with metastatic colon cancer.
- Stage IV Colon Cancer
- Stage IVA Colon Cancer
- Colon Cancer
- Stage IVB Colon Cancer
- Stage IVC Colon Cancer
3 Primary · 0 Secondary · Reporting Duration: Two weeks
2 Treatment Groups
No Microbiome Support
1 of 2
1 of 2
42 Total Participants · 2 Treatment Groups
Primary Treatment: NBT-NM108 · No Placebo Group · Phase 2
Who is running the clinical trial?
Age 18+ · All Participants · 6 Total Inclusion CriteriaMark “Yes” if the following statements are true for you:
Frequently Asked Questions
Is NBT-NM108 a danger to human health?
"While there is some evidence that NBT-NM108 is safe, as this is only a Phase 2 trial, the lack of data regarding efficacy gives it a safety score of 2." - Anonymous Online Contributor
Is this clinical trial taking place at several locations within the state?
"There are presently 10 sites where this study is being conducted. The locations are based in Elizabeth, Newark and Somerville along with other locations 10 other locations. If you participate in this trial, it is important to select the clinic closest to your residence to minimize travel requirements." - Anonymous Online Contributor
Are there any vacancies in this research project for participants?
"Based on the information available from clinicaltrials.gov, it does appear that this trial is still looking for participants. The study was initially posted on May 3rd, 2022 and was edited as recently as October 17th of the same year. There are currently 10 active recruiting sites and the goal is to have 42 patients total enrolled in the trial." - Anonymous Online Contributor
How many people are being included in this trial?
"The clinical trial is currently looking for participants, with the most recent edit on 10/17/2022. The study was originally posted on 5/3/2022 and is searching for 42 patients between 10 sites." - Anonymous Online Contributor